Strong Growth Projected: Anorectal Disorders Treatment Market to Reach $5.38B by 2028 Growing at7.3% CAGR

The anorectal disorders treatment market size has grown strongly in recent years. It will grow from $3.91 billion in 2023 to $4.2 billion in 2024 at a compound annual growth rate (CAGR) of 7.3%. The growth in the historic period can be attributed to aging population, lifestyle factors, increased awareness, on-surgical interventions.

The anorectal disorders treatment market size is expected to see strong growth in the next few years. It will grow to $5.38 billion in 2028 at a compound annual growth rate (CAGR) of 6.4%. The growth in the forecast period can be attributed to demand for patient education, changing dietary habits, demand for telemedicine, research and development activities. Major trends in the forecast period include technological advancements, endoscopy and imaging, public health initiatives.

Market Overview -
Anorectal disorder treatment refers to the treatment involved to treat a group of medical conditions that affect the anal, rectal areas and creates anorectal disorders. These disorders can vary depending on the specific condition and its severity.

Download Free Sample of Report -
https://www.thebusinessresearchcompany.com/sample.aspx?id=12986&type=smp

Rising Geriatric Population Fuels Growth Of Anorectal Disorder Treatment Market
The rising geriatric population is expected to propel the growth of the anorectal disorder treatment market going forward. The geriatric population is the segment of the population that consists of older adults, typically defined as individuals who are 65 or older. Anorectal disorder treatment provides pain management, enhanced hygiene, prevention of recurrence and improves the quality of life of the elderly population suffering from anorectal disorders. For instance, in October 2022, according to the World Health Organization, a US-based specialized health agency, globally, 1 in 6 individuals would be 60 or older by 2030 and is expected to reach 2.1 billion elderly people by 2050. Therefore, the rising geriatric population is driving the growth of the anorectal disorder treatment market.

Competitive Landscape -
Major players in the anorectal disorders treatment market are Cardinal Health Inc., Cigna Corporation., Pfizer Inc., F. Hoffmann-La Roche Ltd., AbbVie Inc., Novartis AG, AstraZeneca PLC, Merck and Co. Inc., Abbott Laboratories, GlaxoSmithKline PLC, Medtronic PLC, Takeda Pharmaceutical Company Limited, Eli Lilly and Company, McKesson Corporation, Teva Pharmaceutical Industries Ltd., Boston Scientific Corporation, Mylan N.V., B. Braun Melsungen AG, Bausch Health Companies Inc., Olympus Corporation, Sun Pharmaceutical Industries Ltd., Ethicon Inc., Coloplast A/S, Teleflex Incorporated, Cook Medical Inc., ConvaTec Group PLC, Lupin Limited, Akorn Inc., NATCO Pharma Limited.

Innovative Medications And Approvals Expand Anorectal Disorder Treatment Market
Major companies operating in the anorectal disorder treatment market are introducing new medications and getting them approved to maximize their position in the market. Drug development leads increase treatment options for anorectal disorders, providing more targeted and effective treatment options for patients, such as Budesonide 2mg Rectal Foam. For instance, in April 2023, Padagis US LLC, a US-based pharmaceutical manufacturer, launched Budesonide 2mg Rectal Foam (generic to Uceris) for anorectal disorders treatment approved by the FDA (Food and Drug Administration), a US-based government agency. Uceris is a prescription corticosteroid drug used to help control active, mild-to-moderate ulcerative colitis, which is an IBD (chronic inflammatory bowel disease) that affects the big intestine.

Browse Full Report @
https://www.thebusinessresearchcompany.com/report/anorectal-disorders-treatment-global-market-report

Key Segments -
The anorectal disorders treatment market covered in this report is segmented -
1) By Treatment: Drugs; Surgery; Other Treatment
2) By Disease: Diarrhea; Hemorrhoid; Abscesse; Fistula; Itching; Other Disease
3) By Route Of Administration: Oral; Parenteral; Rectal; Other Route of administration
4) By End-Users: Hospitals; Specialty Clinics; Other End-Users

Key highlights covered in the report -
1. Detailed market size forecast and historical data analysis
2. Key drivers influencing market growth
3. Identification of upcoming trends and potential opportunities in the market
4. Analysis of major players strategies, to understand competitive dynamics and market positioning
5. Evaluation of regional dynamics

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Want To Know More About The Business Research Company?
The Business Research Company (www.thebusinessresearchcompany.com) is a market intelligence firm that pioneers in company, market, and consumer research. Located globally, TBRC's consultants specialise in various industries including manufacturing, healthcare, financial services, chemicals, and technology.

Global Market Model - World's Most Comprehensive Database
The Business Research Company's flagship product, Global Market Model (www.thebusinessresearchcompany.com/global-market-model) is a market intelligence platform covering various macroeconomic indicators and metrics across 60 geographies and 27 industries. The Global Market Model covers multi-layered datasets which help its users assess supply-demand gaps

This release was published on openPR.